In this issue:
Disease-associated brain activation predicts response to TNF inhibitors in RA
Cancer risk in Sjögren’s disease
Arterial CV outcomes and venous thromboembolism in primary Sjögren’s syndrome
DECT for evaluating bone marrow oedema in RA
Impact of prednisolone initiation and short-term discontinuation on clinical PMR assessment
Two glucocorticoid bridging strategies in early RA and undifferentiated arthritis
Effectiveness of recombinant zoster vaccine in RA
ICI-induced large-vessel vasculitis
Understanding the psoriasis phenotype associated with PsA
DOACs vs. VKAs in antiphospholipid syndrome
Please login below to download this issue (PDF)